{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T13:08:23Z","timestamp":1779109703568,"version":"3.51.4"},"reference-count":64,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","primary-care-diabetes.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Primary Care Diabetes"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.pcd.2026.04.002","type":"journal-article","created":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T22:36:34Z","timestamp":1775514994000},"page":"326-334","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Long-term impact of continuous glucose monitoring on glycemic and metabolic control in type 1 diabetes: A three-year real-world evaluation"],"prefix":"10.1016","volume":"20","author":[{"given":"Ayman","family":"Al Hayek","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wael M.","family":"Al Zahrani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2266-7394","authenticated-orcid":false,"given":"Haifa F.","family":"AlOtaibi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jehad Y.","family":"Saleh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed A.","family":"Al Dawish","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pcd.2026.04.002_bib1","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.2337\/dc23-S002","article-title":"2. Classification and diagnosis of diabetes: standards of care in diabetes\u20142023","volume":"46","author":"ElSayed","year":"2023","journal-title":"Diabetes Care"},{"key":"10.1016\/j.pcd.2026.04.002_bib2","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S2213-8587(22)00218-2","article-title":"Global incidence, prevalence, and mortality of type 1 diabetes in 2021 with projection to 2040: a modelling study","volume":"10","author":"Gregory","year":"2022","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.pcd.2026.04.002_bib3","first-page":"263","article-title":"Use of continuous glucose monitors to manage type 1 diabetes mellitus: progress, challenges, and recommendations","volume":"16","author":"Friedman","year":"2023","journal-title":"Pharm. Pers. Med."},{"key":"10.1016\/j.pcd.2026.04.002_bib4","doi-asserted-by":"crossref","first-page":"S128","DOI":"10.2337\/dc25-S006","article-title":"6. Glycemic goals and hypoglycemia: standards of care in diabetes\u20142025","volume":"48","author":"ElSayed","year":"2025","journal-title":"Diabetes Care"},{"key":"10.1016\/j.pcd.2026.04.002_bib5","first-page":"1","article-title":"Unmet needs in the treatment of type 1 diabetes: why is it so difficult to achieve an improvement in metabolic control?","volume":"14","author":"Mazzotta","year":"2024","journal-title":"Nutr. Diabetes 2024 141"},{"issue":"13","key":"10.1016\/j.pcd.2026.04.002_bib6","first-page":"5669","article-title":"Barriers to type 1 diabetes adherence in adolescents","volume":"13","author":"Azar","year":"2024","journal-title":"J. Clin. Med. 2024"},{"key":"10.1016\/j.pcd.2026.04.002_bib7","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.numecd.2019.01.018","article-title":"The use of real time continuous glucose monitoring or flash glucose monitoring in the management of diabetes: a consensus view of Italian diabetes experts using the Delphi method","volume":"29","author":"Bruttomesso","year":"2019","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"10.1016\/j.pcd.2026.04.002_bib8","doi-asserted-by":"crossref","DOI":"10.1210\/jendso\/bvaa118","article-title":"Minimizing glucose excursions (GEM) with continuous glucose monitoring in type 2 diabetes: a randomized clinical trial","volume":"4","author":"Cox","year":"2020","journal-title":"J. Endocr. Soc."},{"key":"10.1016\/j.pcd.2026.04.002_bib9","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1089\/dia.2020.0396","article-title":"Remote application and use of real-time continuous glucose monitoring by adults with type 2 diabetes in a virtual diabetes clinic","volume":"23","author":"Bergenstal","year":"2021","journal-title":"Diabetes Technol. Ther."},{"key":"10.1016\/j.pcd.2026.04.002_bib10","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1370\/afm.2876","article-title":"Continuous glucose monitoring in primary care: understanding and supporting clinicians\u2019 use to enhance diabetes care","volume":"20","author":"Oser","year":"2022","journal-title":"Ann. Fam. Med."},{"key":"10.1016\/j.pcd.2026.04.002_bib11","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.diabres.2017.08.005","article-title":"Continuous glucose monitoring: a review of the technology and clinical use","volume":"133","author":"Klonoff","year":"2017","journal-title":"Diabetes Res. Clin. Pr."},{"key":"10.1016\/j.pcd.2026.04.002_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1165471","article-title":"Impact of continuous glucose monitoring on glycemic control and its derived metrics in type 1 diabetes: a longitudinal study","volume":"14","author":"Cho","year":"2023","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.pcd.2026.04.002_bib13","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1007\/s13300-022-01253-9","article-title":"Reductions in HbA1c with flash glucose monitoring are sustained for up to 24 months: a meta-analysis of 75 real-world observational studies","volume":"13","author":"Evans","year":"2022","journal-title":"Diabetes Ther."},{"key":"10.1016\/j.pcd.2026.04.002_bib14","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1001\/jama.2016.19975","article-title":"DIAMOND Study Group, effect of continuous glucose monitoring on glycemic control in adults with type 1 diabetes using insulin injections: the DIAMOND randomized clinical trial","volume":"317","author":"Beck","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.pcd.2026.04.002_bib15","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1001\/jama.2020.6940","article-title":"Effect of continuous glucose monitoring on glycemic control in adolescents and young adults with type 1 diabetes: a randomized clinical trial","volume":"323","author":"Laffel","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.pcd.2026.04.002_bib16","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/S2213-8587(23)00061-X","article-title":"Continuous glucose monitoring versus blood glucose monitoring for risk of severe hypoglycaemia and diabetic ketoacidosis in children, adolescents, and young adults with type 1 diabetes: a population-based study","volume":"11","author":"Karges","year":"2023","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.pcd.2026.04.002_bib17","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/S0140-6736(18)30297-6","article-title":"Real-time continuous glucose monitoring in adults with type 1 diabetes and impaired hypoglycaemia awareness or severe hypoglycaemia treated with multiple daily insulin injections (HypoDE): a multicentre, randomised controlled trial","volume":"391","author":"Heinemann","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.pcd.2026.04.002_bib18","doi-asserted-by":"crossref","first-page":"400","DOI":"10.2337\/dc18-1444","article-title":"Validation of time in range as an outcome measure for diabetes clinical trials","volume":"42","author":"Beck","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/j.pcd.2026.04.002_bib19","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.2337\/dci19-0028","article-title":"Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range","volume":"42","author":"Battelino","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/j.pcd.2026.04.002_bib20","doi-asserted-by":"crossref","first-page":"356","DOI":"10.2337\/cd21-0089","article-title":"Improving quality outcomes: the value of diabetes care and education specialists","volume":"40","author":"Rodriguez","year":"2022","journal-title":"Clin. Diabetes"},{"key":"10.1016\/j.pcd.2026.04.002_bib21","first-page":"15","article-title":"Initiating continuous glucose monitoring is associated with improvements in glycemic control and reduced health care resource utilization for people with diabetes in a large US-insured population: a real-world evidence study","volume":"31","author":"Norman","year":"2025","journal-title":"J. Manag. Care Spec. Pharm."},{"key":"10.1016\/j.pcd.2026.04.002_bib22","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1177\/19322968221085273","article-title":"A Glycemia Risk Index (GRI) of hypoglycemia and hyperglycemia for continuous glucose monitoring validated by clinician ratings","volume":"17","author":"Klonoff","year":"2023","journal-title":"J. Diabetes Sci. Technol."},{"key":"10.1016\/j.pcd.2026.04.002_bib23","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1007\/s12020-023-03511-7","article-title":"Impact of glucose variability on the assessment of the glycemia risk index (GRI) and classic glycemic metrics","volume":"82","author":"P\u00e9rez-L\u00f3pez","year":"2023","journal-title":"Endocrine"},{"key":"10.1016\/j.pcd.2026.04.002_bib24","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1001\/jama.2021.6530","article-title":"Association of real-time continuous glucose monitoring with glycemic control and acute metabolic events among patients with insulin-treated diabetes","volume":"325","author":"Karter","year":"2021","journal-title":"JAMA - J. Am. Med. Assoc."},{"key":"10.1016\/j.pcd.2026.04.002_bib25","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.2337\/dc20-0738","article-title":"Effect of flash glucose monitoring on glycemic control, hypoglycemia, diabetes-related distress, and resource utilization in the association of british clinical diabetologists (ABCD) nationwide audit","volume":"43","author":"Deshmukh","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/j.pcd.2026.04.002_bib26","article-title":"Effectiveness of continuous glucose monitoring systems on glycemic control in adults with type 1 diabetes: a systematic review and meta-analysis","volume":"27","author":"Alfadli","year":"2025","journal-title":"Metab. Open"},{"key":"10.1016\/j.pcd.2026.04.002_bib27","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1111\/dom.15328","article-title":"Effects of continuous glucose monitoring on glycaemic control in type 2 diabetes: a systematic review and network meta-analysis of randomized controlled trials","volume":"26","author":"Lu","year":"2024","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.pcd.2026.04.002_bib28","doi-asserted-by":"crossref","first-page":"169","DOI":"10.2337\/dc23-1520","article-title":"Efficacy and safety of continuous glucose monitoring and intermittently scanned continuous glucose monitoring in patients with type 2 diabetes: a systematic review and meta-analysis of interventional evidence","volume":"47","author":"Seidu","year":"2024","journal-title":"Diabetes Care"},{"key":"10.1016\/j.pcd.2026.04.002_bib29","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1001\/jama.2016.19976","article-title":"Continuous glucose monitoring vs conventional therapy for glycemic control in adults with type 1 diabetes treated with multiple daily insulin injections: the GOLD randomized clinical trial","volume":"317","author":"Lind","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.pcd.2026.04.002_bib30","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s12933-025-02747-z","article-title":"Use of an insulin titration protocol based on continuous glucose monitoring in postoperative cardiac surgery patients with type 2 diabetes and prediabetes: a randomized controlled trial","volume":"24","author":"Moon","year":"2025","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.pcd.2026.04.002_bib31","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1089\/dia.2018.0079","article-title":"Continuous glucose monitoring and insulin informed advisory system with automated titration and dosing of insulin reduces glucose variability in type 1 diabetes mellitus","volume":"20","author":"Breton","year":"2018","journal-title":"Diabetes Technol. Ther."},{"key":"10.1016\/j.pcd.2026.04.002_bib32","doi-asserted-by":"crossref","first-page":"S165","DOI":"10.1210\/clinem\/dgaf034","article-title":"Diabetes technology trends: a review of the latest innovations","volume":"110","author":"Lundgrin","year":"2025","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.pcd.2026.04.002_bib33","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/nyas.15262","article-title":"Efficacy and safety of the glucagon receptor antagonist volagidemab in type-1 diabetes: a systematic review and meta-analysis","volume":"1543","author":"Dutta","year":"2025","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.pcd.2026.04.002_bib34","doi-asserted-by":"crossref","DOI":"10.24926\/iip.v16i1.6450","article-title":"Evaluating the effect on total daily insulin dose in adult patients with type 1 diabetes managed with metformin and\/or GLP-1 or GLP-1\/GIP receptor agonists","volume":"16","author":"Ahmed","year":"2025","journal-title":"Innov. Pharm."},{"key":"10.1016\/j.pcd.2026.04.002_bib35","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1111\/j.1463-1326.2006.00686.x","article-title":"Insulin-associated weight gain in diabetes--causes, effects and coping strategies","volume":"9","author":"Russell-Jones","year":"2007","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.pcd.2026.04.002_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2023.110719","article-title":"Determinants of excessive weight gain after the initiation of insulin therapy in type 2 diabetes mellitus: retrospective inception cohort study (ZODIAC 60)","volume":"200","author":"Edens","year":"2023","journal-title":"Diabetes Res. Clin. Pr."},{"key":"10.1016\/j.pcd.2026.04.002_bib37","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s40200-016-0271-5","article-title":"Excess weight gain during insulin pump therapy is associated with higher basal insulin doses","volume":"15","author":"Boucher-Berry","year":"2016","journal-title":"J. Diabetes Metab. Disord."},{"key":"10.1016\/j.pcd.2026.04.002_bib38","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2021-002124","article-title":"Two-year use of flash glucose monitoring is associated with sustained improvement of glycemic control and quality of life (FLARE-NL-6)","volume":"9","author":"Lameijer","year":"2021","journal-title":"BMJ Open Diabetes Res. Care"},{"key":"10.1016\/j.pcd.2026.04.002_bib39","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2337\/dc19-0888","article-title":"Glycemic outcomes in adults with T1D are impacted more by continuous glucose monitoring than by insulin delivery method: 3 years of follow-up from the COMISAIR study","volume":"43","author":"\u0160oupal","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/j.pcd.2026.04.002_bib40","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s12966-024-01692-6","article-title":"The efficacy of using continuous glucose monitoring as a behaviour change tool in populations with and without diabetes: a systematic review and meta-analysis of randomised controlled trials","volume":"21","author":"Richardson","year":"2024","journal-title":"Int. J. Behav. Nutr. Phys. Act."},{"key":"10.1016\/j.pcd.2026.04.002_bib41","article-title":"Characterising the design and methods of continuous glucose monitoring used in behavioural interventions to inform future research in prediabetes","volume":"7","author":"Black","year":"2025","journal-title":"Lancet Digit. Health"},{"key":"10.1016\/j.pcd.2026.04.002_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdiacomp.2022.108385","article-title":"Intermittent-scanned continuous glucose monitoring with low glucose alarms decreases hypoglycemia incidence in middle-aged adults with type 1 diabetes in real-life setting","volume":"37","author":"Oriot","year":"2023","journal-title":"J. Diabetes Complicat."},{"key":"10.1016\/j.pcd.2026.04.002_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2025.112074","article-title":"Continuous glucose monitoring with low-glucose alerts in insulin-treated drivers with diabetes: a randomized crossover study","volume":"222","author":"Maeda","year":"2025","journal-title":"Diabetes Res. Clin. Pr."},{"key":"10.1016\/j.pcd.2026.04.002_bib44","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1177\/1932296819831695","article-title":"Impact of CGM on the management of hypoglycemia problems: overview and secondary analysis of the HypoDE study","volume":"13","author":"Hermanns","year":"2019","journal-title":"J. Diabetes Sci. Technol."},{"key":"10.1016\/j.pcd.2026.04.002_bib45","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1001\/jama.2013.277818","article-title":"Effect of sensor-augmented insulin pump therapy and automated insulin suspension vs standard insulin pump therapy on hypoglycemia in patients with type 1 diabetes: a randomized clinical trial","volume":"310","author":"Ly","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.pcd.2026.04.002_bib46","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S2213-8587(16)30193-0","article-title":"Continuous glucose monitoring for patients with type 1 diabetes and impaired awareness of hypoglycaemia (IN CONTROL): a randomised, open-label, crossover trial","volume":"4","author":"van Beers","year":"2016","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.pcd.2026.04.002_bib47","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.2337\/dc14-0030","article-title":"Recovery of hypoglycemia awareness in long-standing type 1 diabetes: a multicenter 2 \u00d7 2 factorial randomized controlled trial comparing insulin pump with multiple daily injections and continuous with conventional glucose self-monitoring (HypoCOMPaSS)","volume":"37","author":"Little","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/j.pcd.2026.04.002_bib48","doi-asserted-by":"crossref","DOI":"10.2337\/db24-239-OR","article-title":"239-OR: CGM has a specific effect on the reduction of nocturnal hypoglycemia in people with type 1 diabetes on an MDI treatment regimen","volume":"73","author":"Hermanns","year":"2024","journal-title":"Diabetes"},{"key":"10.1016\/j.pcd.2026.04.002_bib49","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3803\/EnM.2025.2370","article-title":"Advances in continuous glucose monitoring: clinical applications","volume":"40","author":"Kwon","year":"2025","journal-title":"Endocrinol. Metab. Seoul. Korea"},{"key":"10.1016\/j.pcd.2026.04.002_bib50","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.2337\/dc20-0112","article-title":"Real-time CGM is superior to flash glucose monitoring for glucose control in type 1 diabetes: the CORRIDA randomized controlled trial","volume":"43","author":"H\u00e1skov\u00e1","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/j.pcd.2026.04.002_bib51","doi-asserted-by":"crossref","first-page":"854","DOI":"10.2337\/dc22-2189","article-title":"Initiation of continuous glucose monitoring is linked to improved glycemic control and fewer clinical events in type 1 and type 2 diabetes in the veterans health administration","volume":"46","author":"Reaven","year":"2023","journal-title":"Diabetes Care"},{"key":"10.1016\/j.pcd.2026.04.002_bib52","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2020-001848","article-title":"Therapy adjustments in people with type 1 diabetes with impaired hypoglycemia awareness on multiple daily injections using real-time continuous glucose monitoring: a mechanistic analysis of the HypoDE study","volume":"9","author":"Waldenmaier","year":"2021","journal-title":"BMJ Open Diabetes Res. Care"},{"key":"10.1016\/j.pcd.2026.04.002_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2025.112228","article-title":"Continuous glucose monitoring as equinox of nocturnal and daytime hypoglycaemia in type 1 diabetes: insights from the randomized controlled HypoDE trial","volume":"224","author":"Hermanns","year":"2025","journal-title":"Diabetes Res. Clin. Pr."},{"key":"10.1016\/j.pcd.2026.04.002_bib54","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1089\/dia.2021.0503","article-title":"Benefit of continuous glucose monitoring in reducing hypoglycemia is sustained through 12 months of use among older adults with type 1 diabetes","volume":"24","author":"Miller","year":"2022","journal-title":"Diabetes Technol. Ther."},{"key":"10.1016\/j.pcd.2026.04.002_bib55","doi-asserted-by":"crossref","DOI":"10.2337\/db24-1777-LB","article-title":"1777-LB: time below range is correlated with level 2 (L2) hypoglycemia event rates in type 1 diabetes\u2014results from DCLP3, DIAMOND, and WISDM Trials","volume":"73","author":"Liggins","year":"2024","journal-title":"Diabetes"},{"key":"10.1016\/j.pcd.2026.04.002_bib56","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.2337\/dc20-1690","article-title":"Important drop in rate of acute diabetes complications in people with type 1 or type 2 diabetes after initiation of flash glucose monitoring in france: the RELIEF study","volume":"44","author":"Roussel","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/j.pcd.2026.04.002_bib57","doi-asserted-by":"crossref","first-page":"5202","DOI":"10.1111\/dom.15866","article-title":"Impact of continuous glucose monitoring on hospitalizations and glucose control in people with type 2 diabetes: real-world analysis","volume":"26","author":"Garg","year":"2024","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.pcd.2026.04.002_bib58","volume":"19\u201320","author":"Khowaja","year":"2025","journal-title":"Diabetes Epidemiol. Manag."},{"key":"10.1016\/j.pcd.2026.04.002_bib59","first-page":"S21","article-title":"Impact of continuous glucose monitoring on emergency department visits and all-cause hospitalization rates among Medicaid beneficiaries with type 2 diabetes treated with multiple daily insulin or basal insulin therapy","volume":"30","author":"Hirsch","year":"2024","journal-title":"J. Manag. Care Spec. Pharm."},{"key":"10.1016\/j.pcd.2026.04.002_bib60","series-title":"Biomarkers of Glycemic Control","article-title":"Monitoring Technologies- Continuous Glucose Monitoring, Mobile Technology","author":"Reddy","year":"2000"},{"key":"10.1016\/j.pcd.2026.04.002_bib61","first-page":"S-14","article-title":"Continuous and intermittent glucose monitoring in 2023","volume":"26","author":"Dovc","year":"2024"},{"key":"10.1016\/j.pcd.2026.04.002_bib62","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1007\/s12325-021-01765-z","article-title":"Frequency of diabetic ketoacidosis in patients with type 1 diabetes using freestyle libre: a retrospective chart review","volume":"38","author":"Al Hayek","year":"2021","journal-title":"Adv. Ther."},{"key":"10.1016\/j.pcd.2026.04.002_bib63","doi-asserted-by":"crossref","first-page":"S146","DOI":"10.2337\/dc25-S007","article-title":"7. Diabetes technology: standards of care in diabetes\u20142025","volume":"48","year":"2025","journal-title":"Diabetes Care"},{"key":"10.1016\/j.pcd.2026.04.002_bib64","doi-asserted-by":"crossref","DOI":"10.1177\/19322968251321860","article-title":"Implications of the glycemia risk index in assessing metabolic control and its correlation with therapy-related quality of life during-Ramadan fasting in adults with type 2 diabetes","author":"Al Hayek","year":"2025","journal-title":"J. Diabetes Sci. Technol."}],"container-title":["Primary Care Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1751991826000732?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1751991826000732?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T12:24:53Z","timestamp":1779107093000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1751991826000732"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":64,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S1751991826000732"],"URL":"https:\/\/doi.org\/10.1016\/j.pcd.2026.04.002","relation":{},"ISSN":["1751-9918"],"issn-type":[{"value":"1751-9918","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term impact of continuous glucose monitoring on glycemic and metabolic control in type 1 diabetes: A three-year real-world evaluation","name":"articletitle","label":"Article Title"},{"value":"Primary Care Diabetes","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pcd.2026.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Primary Care Diabetes Europe. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}